Preparation method of vitamin D3
Through the multi-step photochemical reaction and thermal isomer combination, combined with the filter liquid narrowing the ultraviolet wavelength and protective agent, the problems of increasing by-products and low selectivity in vitamin D3 synthesis in the prior art are solved, and efficient Vitamin D3 preparation.
Patent Information
- Application Number
- CN202411124325.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-26
AI Technical Summary
In the existing vitamin D3 synthesis process, the conversion rate of 7-dehydrogen cholesterol is inversely proportional to the selectivity of previtamin D3 and vitamin D3, resulting in an increase in by-products. Vitamin D3 is easily destroyed under ultraviolet light, making it difficult to achieve high conversion rate and Selective.
采用多步光化学反应与热异构的方法,首先在有机碱和抗氧化剂的保护下进行光化学反应,随后进行热异构,最后通过滤光液窄化紫外光波长进行第二次光化学反应,结合 Protective agent (2,4,6-trimethylbenzoyl) diphenylphosphine oxide to inhibit the destruction of vitamin D3.
It effectively improves the yield and selectivity of vitamin D3, reduces the production of impurities, prevents the destruction of vitamin D3, and achieves high selectivity and conversion rate process production.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The invention relates to the field of chemical synthesis, and in particular to a method for preparing vitamin D3. Background Art
[0002] Vitamin D3 is a fat-soluble vitamin that can dissolve in organic matter. It is known as the "sunshine vitamin" and is an indispensable vitamin for humans and animals. It has multiple physiological functions: improving the body's absorption of calcium and phosphorus, so that the levels of plasma calcium and plasma phosphorus reach saturation; promoting growth and bone calcification, and promoting healthy teeth; increasing phosphorus absorption through the intestinal wall and phosphorus reabsorption through the renal tubules; maintaining normal levels of citrate in the blood; and preventing amino acid loss through the kidneys. Human skin contains a type of cholesterol that can be converted into vitamin D3 after exposure to sunlight.
[0003] The existing process for synthesizing vitamin D3 is to irradiate 7-dehydrocholesterol with ultraviolet light. In photochemical synthesis, the wavelength of ultraviolet light plays a decisive role.
[0004] A single ultraviolet wavelength is the best light source. Patent US07211172 reports a method of synthesizing vitamin D3 by two-step laser radiation using ultraviolet light of 254nm+313nm wavelength as the light source, and finally obtains a product of 5.7% tachysterol impurity, 81.9% previtamin D3, and 8.3% tachysterol. Although laser radiation can achieve a good level, high-power laser light sources are extremely expensive and are still not suitable for industrial production at this stage.
[0005] The existing industrial production still uses mercury lamps as the main light source. Since mercury lamps emit ultraviolet light and a lot of visible light with a wide wavelength range, there are many by-products when preparing vitamin D3. Chinese patent CN101085755B uses a narrowed mercury lamp wavelength and a one-step photochemical method to increase the conversion rate of pre-vitamin D3 to about 68%, but does not mention the content of by-products. At present, the main problem in the process of synthesizing vitamin D3 is that the conversion rate of 7-dehydrocholesterol is inversely proportional to the selectivity of pre-vitamin D3 and vitamin D3. As the conversion rate of 7-dehydrocholesterol increases, the selectivity of the main product decreases, and the by-products increase, such as:
[0006]
[0007] The conversion rate of 7-dehydrocholesterol is affected by the wavelength, temperature, concentration and illumination time of light. As the conversion rate of 7-dehydrocholesterol increases, the total amount of impurities also increases, resulting in a decrease in the selectivity of pre-vitamin D3 and vitamin D3. At the same time, vitamin D3 will be destroyed under ultraviolet light. The complex conversion equilibrium system of vitamin D3 is the difficulty in the current production of vitamin D3. How to choose a 7-dehydrocholesterol conversion rate as high as possible while reducing the generation of impurities is of great significance in the production of vitamin D3. Summary of the invention
[0008] There is a complex balance between luminosterol, tachysterol, pre-vitamin D3 and trans-vitamin D3. Multiple factors jointly affect the conversion rate of 7-dehydrocholesterol and the selectivity of vitamin D3. In order to improve both the conversion rate and selectivity,
[0009] The present invention provides a method for preparing vitamin D3, comprising:
[0010] S1: 7-dehydrocholesterol, an organic base and an antioxidant are mixed with an organic solvent to form an organic solution, and the organic solution is continuously passed through a quartz falling film photoreactor equipped with a mercury lamp to perform a photochemical reaction;
[0011] S2: collecting the photochemical reaction liquid of step S1 and performing thermal isomerization reaction;
[0012] S3: The thermal isomerization reaction liquid of step S2 is continuously passed through a quartz rising film photoreactor equipped with a filter liquid and a mercury lamp to carry out a second photochemical reaction. The reaction liquid after the photochemical reaction is concentrated under reduced pressure, crystallized, and filtered. After the organic base is removed from the filtrate, it is concentrated and thermally isomerized to obtain the vitamin D3 product.
[0013] In some embodiments, the flow rate of the organic solution in step S1 through the photoreactor is 200ml / min to 400ml / min. In some embodiments, the flow rate of the organic solution in step S1 through the photoreactor is 200ml / min. In some embodiments, the flow rate of the organic solution in step S1 through the photoreactor is 300ml / min. In some embodiments, the flow rate of the organic solution in step S1 through the photoreactor is 400ml / min.
[0014] In some embodiments, the photochemical reaction temperature of step S1 is 5-25°C, in some embodiments, the photochemical reaction temperature of step S1 is 5°C, in some embodiments, the photochemical reaction temperature of step S1 is 10°C, in some embodiments, the photochemical reaction temperature of step S1 is 15°C, in some embodiments, the photochemical reaction temperature of step S1 is 20°C, and in some embodiments, the photochemical reaction temperature of step S1 is 25°C.
[0015] In some embodiments, the organic base in step S1 is pyridine and / or 2-methylpyridine.
[0016] In some embodiments, the molar ratio of the organic base in step S1 to 7-dehydrocholesterol is 1:100 to 1:20. In some embodiments, the molar ratio of the organic base in step S1 to 7-dehydrocholesterol is 1:50. In some embodiments, the molar ratio of the organic base in step S1 to 7-dehydrocholesterol is 1:100. In some embodiments, the molar ratio of the organic base in step S1 to 7-dehydrocholesterol is 1:90. In some embodiments, the molar ratio of the organic base in step S1 to 7-dehydrocholesterol is 1:80. In some embodiments, the molar ratio of the organic base in step S1 to 7-dehydrocholesterol is 1:10 ... The molar ratio of the organic base to 7-dehydrocholesterol is 1:70. In some embodiments, the molar ratio of the organic base to 7-dehydrocholesterol in step S1 is 1:60. In some embodiments, the molar ratio of the organic base to 7-dehydrocholesterol in step S1 is 1:50. In some embodiments, the molar ratio of the organic base to 7-dehydrocholesterol in step S1 is 1:40. In some embodiments, the molar ratio of the organic base to 7-dehydrocholesterol in step S1 is 1:30. In some embodiments, the molar ratio of the organic base to 7-dehydrocholesterol in step S1 is 1:20.
[0017] In some embodiments, the antioxidant in step S1 is selected from one or a combination of butylated hydroxyanisole, 2,6-di-tert-butyl-4-methylphenol, and tert-butylhydroquinone.
[0018] In some embodiments, the molar ratio of the antioxidant to 7-dehydrocholesterol in step S1 is 1:(10-100). In some preferred embodiments, the molar ratio of the antioxidant to 7-dehydrocholesterol in step S1 is 1:(10-20). In some embodiments, the molar ratio of the antioxidant to 7-dehydrocholesterol in step S1 is 1:100. In some embodiments, the molar ratio of the antioxidant to 7-dehydrocholesterol in step S1 is 1:90. In some embodiments, the molar ratio of the antioxidant to 7-dehydrocholesterol in step S1 is 1:80. The molar ratio of the antioxidant to 7-dehydrocholesterol in step S1 is 1:70, the molar ratio of the antioxidant to 7-dehydrocholesterol in step S1 is 1:60, in some embodiments, the molar ratio of the antioxidant to 7-dehydrocholesterol in step S1 is 1:50, in some embodiments, the molar ratio of the antioxidant to 7-dehydrocholesterol in step S1 is 1:40, in some embodiments, the molar ratio of the antioxidant to 7-dehydrocholesterol in step S1 is 1:30, in some embodiments, the molar ratio of the antioxidant to 7-dehydrocholesterol in step S1 is 1:20, in some embodiments, the molar ratio of the antioxidant to 7-dehydrocholesterol in step S1 is 1:10.
[0019] In some embodiments, the organic solvent in step S1 is selected from a mixture or monomer of alcohol, ether, and an alkane with 5 to 8 carbon atoms.
[0020] In some embodiments, the organic solvent in step S1 is selected from one or a combination of methanol, ethanol, and petroleum ether.
[0021] In some embodiments, the thermal isomerization reaction temperature of step S2 is 60-90°C, in some preferred embodiments, the thermal isomerization reaction temperature of step S2 is 90°C, in some embodiments, the thermal isomerization reaction temperature of step S2 is 60°C, in some embodiments, the thermal isomerization reaction temperature of step S2 is 70°C, in some embodiments, the thermal isomerization reaction temperature of step S2 is 80°C, in some embodiments, the thermal isomerization reaction temperature of step S2 is 90°C.
[0022] In some embodiments, the thermal isomerization reaction time of step S2 is 1 to 6 hours, in some preferred embodiments, the thermal isomerization reaction time of step S2 is 1 to 3 hours, in some embodiments, the thermal isomerization reaction time of step S2 is 1 hour, in some embodiments, the thermal isomerization reaction time of step S2 is 2 hours, in some embodiments, the thermal isomerization reaction time of step S2 is 3 hours, in some embodiments, the thermal isomerization reaction time of step S2 is 4 hours, in some embodiments, the thermal isomerization reaction time of step S2 is 5 hours, in some embodiments, the thermal isomerization reaction time of step S2 is 6 hours.
[0023] In some embodiments, the flow rate of the thermal isomerization reaction liquid in step S3 through the photoreactor is 20-50 ml / min. In some embodiments, the flow rate of the thermal isomerization reaction liquid in step S3 through the photoreactor is 20 ml / min. In some embodiments, the flow rate of the thermal isomerization reaction liquid in step S3 through the photoreactor is 30 ml / min. In some embodiments, the flow rate of the thermal isomerization reaction liquid in step S3 through the photoreactor is 40 ml / min. In some embodiments, the flow rate of the thermal isomerization reaction liquid in step S3 through the photoreactor is 50 ml / min.
[0024] In some embodiments, the photochemical reaction temperature of step S3 is 30-60°C, in some embodiments, the photochemical reaction temperature of step S3 is 60°C, in some embodiments, the photochemical reaction temperature of step S3 is 50°C, in some embodiments, the photochemical reaction temperature of step S3 is 40°C, in some embodiments, the photochemical reaction temperature of step S3 is 30°C.
[0025] In some embodiments, the thermal isomerization and concentration in step S3 occur simultaneously.
[0026] In some embodiments, the thermal isomerization reaction temperature of step S3 is greater than 60°C, in some preferred embodiments, it is 60-90°C, in some embodiments, the thermal isomerization reaction temperature of step S3 is 60°C, in some embodiments, the thermal isomerization reaction temperature of step S3 is 70°C, in some embodiments, the thermal isomerization reaction temperature of step S3 is 80°C, in some embodiments, the thermal isomerization reaction temperature of step S3 is 90°C.
[0027] In some embodiments, the filter liquid in step S3 includes pyridinium salt and ethylene glycol. In some preferred embodiments, the filter liquid in step S3 also includes a protective agent (2,4,6-trimethylbenzoyl) diphenylphosphine oxide.
[0028] In some embodiments, the pyridinium salt in step S3 is a strong acid or a weak acid salt of pyridine.
[0029] In some embodiments, the strong acid or weak acid salt of pyridine in step S3 is selected from pyridine hydrochloride, pyridine acetate, and pyridine sulfate.
[0030] In some embodiments, the mass fraction concentration of the pyridinium salt in step S3 is 1% to 5%, in some embodiments, the mass fraction concentration of the pyridinium salt in step S3 is 1%, in some embodiments, the mass fraction concentration of the pyridinium salt in step S3 is 2%, in some embodiments, the mass fraction concentration of the pyridinium salt in step S3 is 3%, in some embodiments, the mass fraction concentration of the pyridinium salt in step S3 is 4%, in some embodiments, the mass fraction concentration of the pyridinium salt in step S3 is 5%.
[0031] In some embodiments, the mass fraction concentration of (2,4,6-trimethylbenzoyl) diphenyl phosphine oxide in step S3 is 0.1% to 1%. In some embodiments, the mass fraction concentration of (2,4,6-trimethylbenzoyl) diphenyl phosphine oxide in step S3 is 0.2% to 0.9%. In some embodiments, the mass fraction concentration of (2,4,6-trimethylbenzoyl) diphenyl phosphine oxide in step S3 is 0.3% to 0.8%. In some embodiments, the mass fraction concentration of (2,4,6-trimethylbenzoyl) diphenyl phosphine oxide in step S3 is 0.4% to 0.7%. In some embodiments, the mass fraction concentration of (2,4,6-trimethylbenzoyl) diphenyl phosphine oxide in step S3 is 0.5% to 0.6%.
[0032] The advantages of the present invention are:
[0033] By adding a combination of an organic base and an antioxidant, wherein the organic base is pyridine or 2-methylpyridine, a filter liquid is used to narrow the wavelength of ultraviolet light, and a multi-step photochemical reaction is combined with thermal isomerization to achieve a higher vitamin D3 yield. The reaction direction of producing sterol impurities (tachysterol and photosterol) can be effectively inhibited, and the reaction equilibrium is pushed toward the direction of pre-vitamin D3 and vitamin D3. At the same time, vitamin D3 is prevented from being destroyed to produce trans-vitamin D3, thereby achieving high selectivity and conversion rate of process production.
[0034] The method of multi-step photochemical reaction and thermal isomerization is specifically as follows: under the protection of a combination of an organic base and an antioxidant, light isomerization is first performed once to achieve a higher conversion rate, at which time the contents of tachysterol and pre-vitamin D3 are both high; pre-vitamin D3 is then thermally isomerized into vitamin D3 to prevent pre-vitamin D3 from being converted into impurities in the second photochemical reaction, resulting in a decrease in selectivity; a second photochemical reaction is then carried out using a filter to narrow the wavelength of ultraviolet light, so that tachysterol is slowly converted into pre-vitamin D3. Furthermore, adding a protective agent (2,4,6-trimethylbenzoyl) diphenylphosphine oxide to the filter can largely prevent vitamin D3 from being destroyed, thereby achieving the purpose of simultaneously improving conversion rate and selectivity. DETAILED DESCRIPTION
[0035] Through the following further detailed description of the embodiments of the present invention in combination with specific implementation modes, those skilled in the art will more clearly and thoroughly understand the further features, advantages and effects of the present invention.
[0036] Vitamin D3 in the following examples was detected by high performance liquid chromatography, instrument: Agilent 1260; column: Dalian Elite Hypersil ODS25um×4.6mm×250mm; mobile phase: methanol: water=95:5; column temperature: 30°C; detector: UV254nm; flow rate: 1.0ml / min; analysis time: 45min; injection volume: 20μl.
[0037] Mercury lamp, brand: Heraeus, Germany, model: AM2001X-Haisen, wavelength range: 200-600nm, main peak: 365nm.
[0038] Photoreactor, brand: Vollabor Instruments, model: FFPR-700mL;
[0039] FFPR-700mL, in the following embodiments, when the reaction liquid enters from the top and flows from top to bottom, it can be used as a quartz falling film photoreactor; when the reaction liquid enters from the bottom and flows from bottom to top, it can be used as a quartz rising film photoreactor. The FFPR-700mL can be purchased on the open market. This model is used to clearly express the technical solution of the present invention and facilitate the implementation of the technical solution of the present invention. This model does not constitute a limitation on the technical solution of the present invention. The structure of the instrument is clear and unique. Devices with different models but the same structure should be regarded as within the protection scope of the technical solution of the present invention.
[0040]
[0041] Where m a is the mass of 7-dehydrocholesterol fed;
[0042] m b is the remaining mass of 7-dehydrocholesterol;
[0043] n a is the amount of 7-dehydrocholesterol added;
[0044] n b is the amount of the remaining 7-dehydrocholesterol substance;
[0045] n c It is the amount of substance of vitamin D3.
[0046] Example 1
[0047] 90 g (content 95.5%, 0.22 mol) of 7-dehydrocholesterol was dissolved in 3000 mL of ethanol, 0.35 g of pyridine and 2.01 g of butylated hydroxyanisole were added, and the solution was passed through a quartz falling film photoreactor equipped with a mercury lamp at a flow rate of 300 ml / min, with a residence time of 16 s, wherein the quartz falling film photoreactor was equipped with cooling water, and the reaction liquid temperature T1 was controlled to be 25° C., and the reaction liquid was collected;
[0048] The above reaction solution was heated at 90°C for 1 h under nitrogen protection to obtain an isomeric solution;
[0049] The isomerized liquid was passed through a quartz rising film photoreactor equipped with a mercury lamp at a flow rate of 30 ml / min, with a residence time of 600 s, wherein the quartz rising film photoreactor was equipped with a filter liquid (2.5% pyridine hydrochloride, 0.5% (2,4,6-trimethylbenzoyl) diphenylphosphine oxide and 10% ethylene glycol in deionized water), the temperature of the reaction liquid was controlled at 40°C, and the photochemical liquid was collected;
[0050] The photochemical liquid was subjected to reduced pressure crystallization to precipitate a solid, which was dried to obtain 51.77 g of 7-dehydrocholesterol with a content of 95.8%;
[0051] The mother liquor was passed through a large-pore carboxyl weak acid resin column D131 to remove pyridine, and the obtained filtrate was concentrated under reduced pressure at 60°C to obtain 35.92 g of a mixture with a vitamin D3 content of 82.4 wt%, of which the tachysterol content was 5.8 wt%, the conversion rate of 7-dehydrocholesterol was 42.3%, and the selectivity was 81.4%.
[0052] Example 2
[0053] 90 g (content 95.5%, 0.22 mol) of 7-dehydrocholesterol was dissolved in 3000 mL (volume ratio of 1:3) of a mixed solvent of methanol and petroleum ether, 0.88 g of pyridine and 0.80 g of butylated hydroxyanisole were added, and the solution was passed through a quartz falling film photoreactor equipped with a mercury lamp at a flow rate of 300 ml / min for a residence time of 16 s, wherein the quartz falling film photoreactor was equipped with cooling water, and the reaction liquid temperature T1 was controlled to be 5° C., and the reaction liquid was collected;
[0054] The above reaction solution was heated at 60°C for 5 h under nitrogen protection to obtain an isomeric solution;
[0055] The isomerized liquid was passed through a quartz rising film photoreactor equipped with a mercury lamp at a flow rate of 30 ml / min for a residence time of 300 s, wherein the quartz rising film photoreactor was equipped with a filter liquid (2.5% pyridine hydrochloride, 0.5% (2,4,6-trimethylbenzoyl) diphenylphosphine oxide and 10% ethylene glycol in deionized water), the temperature of the reaction liquid was controlled at 60°C, and the photochemical liquid was collected;
[0056] The photochemical liquid was subjected to reduced pressure crystallization to precipitate a solid, which was dried to obtain 52.87 g of 7-dehydrocholesterol with a content of 95.1%;
[0057] The mother liquor was passed through a large-pore carboxyl weak acid resin column D131 to remove pyridine, and the obtained filtrate was concentrated under reduced pressure at 60°C to obtain 35.71 g of a mixture, wherein the vitamin D3 content was 80.1 wt%, the tachysterol content was 4.5 wt%, the conversion rate of 7-dehydrocholesterol was 41.5%, and the selectivity was 80.2%.
[0058] Example 3
[0059] 90 g (content 95.5%, 0.22 mol) of 7-dehydrocholesterol was dissolved in 3000 mL of ethanol, 0.42 g of 2-methylpyridine and 2.46 g of 2,6-di-tert-butyl-4-methylphenol were added, and the solution was passed through a quartz falling film photoreactor equipped with a mercury lamp at a flow rate of 200 ml / min, with a residence time of 24 s, wherein the quartz falling film photoreactor was equipped with cooling water, and the reaction liquid temperature T1 was controlled to be 5° C., and the reaction liquid was collected;
[0060] The above reaction solution was heated at 80°C for 3 h under nitrogen protection to obtain an isomeric solution;
[0061] The isomerized liquid was passed through a quartz rising film photoreactor equipped with a mercury lamp at a flow rate of 50 ml / min, with a residence time of 360 s, wherein the quartz rising film photoreactor was equipped with a filter liquid (5% pyridine acetate, 1% (2,4,6-trimethylbenzoyl) diphenylphosphine oxide and 10% ethylene glycol in deionized water), the temperature of the reaction liquid was controlled at 30°C, and the photochemical liquid was collected;
[0062] The photochemical liquid was subjected to reduced pressure crystallization to precipitate solids, which were dried to obtain 49.45 g of 7-dehydrocholesterol with a content of 94.9%;
[0063] The mother liquor was passed through a large-pore carboxyl weak acid resin column D131 to remove 2-methylpyridine, and the obtained filtrate was concentrated under reduced pressure at 60°C to obtain 39.85 g of a mixture, wherein the vitamin D3 content was 75.2 wt%, the tachysterol content was 6.2 wt%, the conversion rate of 7-dehydrocholesterol was 45.4%, and the selectivity was 76.8%.
[0064] Example 4
[0065] 90 g (content 95.5%, 0.22 mol) of 7-dehydrocholesterol was dissolved in 3000 mL (volume ratio of 1:3) of a mixed solvent of methanol and petroleum ether, 0.53 g of pyridine and 3.94 g of 2,6-di-tert-butyl-4-methylphenol were added, and the solution was passed through a quartz falling film photoreactor equipped with a mercury lamp at a flow rate of 400 ml / min for a residence time of 12 s, wherein the quartz falling film photoreactor was equipped with cooling water, and the reaction liquid temperature T1 was controlled to be 15° C., and the reaction liquid was collected;
[0066] The above reaction solution was heated at 70°C for 4 h under nitrogen protection to obtain an isomeric solution;
[0067] The isomerized liquid was passed through a quartz rising film photoreactor equipped with a mercury lamp at a flow rate of 20 ml / min, with a residence time of 900 s, wherein the quartz rising film photoreactor was equipped with a filter liquid (1% pyridine sulfate, 0.5% (2,4,6-trimethylbenzoyl) diphenylphosphine oxide and 10% ethylene glycol in deionized water), the temperature of the reaction liquid was controlled at 50° C., and the photochemical liquid was collected;
[0068] The photochemical liquid was subjected to reduced pressure crystallization to precipitate solids, which were dried to obtain 55.92 g of 7-dehydrocholesterol with a content of 95.6%;
[0069] The mother liquor was passed through a large-pore carboxyl weak acid resin column D131 to remove pyridine, and the obtained filtrate was concentrated under reduced pressure at 60°C to obtain 34.37 g of a mixture, wherein the vitamin D3 content was 74.2 wt%, the tachysterol content was 3.85 wt%, the conversion rate of 7-dehydrocholesterol was 37.8%, and the selectivity was 78.5%.
[0070] Example 5
[0071] 90 g (content 95.5%, 0.22 mol) of 7-dehydrocholesterol was dissolved in 3000 mL (volume ratio of 1:3) of a mixed solvent of methanol and petroleum ether, 0.42 g of 2-methylpyridine and 1.86 g of tert-butylhydroquinone were added, and the solution was passed through a quartz falling film photoreactor equipped with a mercury lamp at a flow rate of 300 ml / min, with a residence time of 16 s, wherein the quartz falling film photoreactor was equipped with cooling water, and the reaction liquid temperature T1 was controlled to be 25° C., and the reaction liquid was collected;
[0072] The above reaction solution was heated at 60°C for 5 h under nitrogen protection to obtain an isomeric solution;
[0073] The isomerized liquid was passed through a quartz rising film photoreactor equipped with a mercury lamp at a flow rate of 30 ml / min, with a residence time of 600 s, wherein the quartz rising film photoreactor was equipped with a filter liquid (5% pyridine hydrochloride, 0.1% (2,4,6-trimethylbenzoyl) diphenylphosphine oxide and 10% ethylene glycol in deionized water), the temperature of the reaction liquid was controlled at 40°C, and the photochemical liquid was collected;
[0074] The photochemical liquid was subjected to reduced pressure crystallization to precipitate solids, which were dried to obtain 57.30 g of 7-dehydrocholesterol with a content of 92.4%;
[0075] The mother liquor was passed through a large-pore carboxyl weakly acidic resin column D131 to remove 2-methylpyridine, and the obtained filtrate was concentrated under reduced pressure at 60°C to obtain 33.90 g of a mixture, wherein the vitamin D3 content was 77.6 wt%, the tachysterol content was 7.9 wt%, the conversion rate of 7-dehydrocholesterol was 38.4%, and the selectivity was 79.7%.
[0076] Comparative Example 1: (Replacing the organic base with diethylamine)
[0077] 90 g (content 95.5%, 0.22 mol) of 7-dehydrocholesterol was dissolved in 3000 mL of ethanol, 0.27 g of ethylenediamine and 2.01 g of butylated hydroxyanisole were added, and the solution was passed through a quartz falling film photoreactor equipped with a mercury lamp at a flow rate of 300 ml / min, with a residence time of 16 s, wherein the quartz falling film photoreactor was equipped with cooling water, and the reaction liquid temperature T1 was controlled to be 25° C., and the reaction liquid was collected;
[0078] The above reaction solution was heated at 90°C for 1 h under nitrogen protection to obtain an isomeric solution;
[0079] The isomerized liquid was passed through a quartz rising film photoreactor equipped with a mercury lamp at a flow rate of 30 ml / min, with a residence time of 600 s, wherein the quartz rising film photoreactor was equipped with a filter liquid (2.5% pyridine hydrochloride, 0.5% (2,4,6-trimethylbenzoyl) diphenylphosphine oxide and 10% ethylene glycol in deionized water), the temperature of the reaction liquid was controlled at 40°C, and the photochemical liquid was collected;
[0080] The photochemical liquid was subjected to reduced pressure crystallization to precipitate a solid, which was dried to obtain 55.16 g of 7-dehydrocholesterol with a content of 93.8%;
[0081] The mother liquor was passed through a large-pore carboxyl weakly acidic resin column D131 to remove ethylenediamine, and the obtained filtrate was concentrated under reduced pressure at 60°C to obtain 35.89 g of a mixture, wherein the vitamin D3 content was 62.4 wt%, the tachysterol content was 7.1 wt%, the conversion rate of 7-dehydrocholesterol was 39.8%, and the selectivity was 70.4%.
[0082] Comparative Example 2 (no (2,4,6-trimethylbenzoyl)diphenylphosphine oxide in the filter liquid)
[0083] 90 g (content 95.5%, 0.22 mol) of 7-dehydrocholesterol was dissolved in 3000 mL of ethanol, 0.35 g of pyridine and 2.01 g of butylated hydroxyanisole were added, and the solution was passed through a quartz falling film photoreactor equipped with a mercury lamp at a flow rate of 300 ml / min, with a residence time of 16 s, wherein the quartz falling film photoreactor was equipped with cooling water, and the reaction liquid temperature T1 was controlled to be 25° C., and the reaction liquid was collected;
[0084] The above reaction solution was heated at 90°C for 1 h under nitrogen protection to obtain an isomeric solution;
[0085] The isomerized liquid was passed through a quartz rising film photoreactor equipped with a mercury lamp at a flow rate of 30 ml / min, with a residence time of 600 s, wherein the quartz rising film photoreactor was equipped with a filter liquid (2.5% pyridine hydrochloride, 10% ethylene glycol in deionized water), the temperature of the reaction liquid was controlled at 40°C, and the photochemical liquid was collected;
[0086] The photochemical liquid was subjected to reduced pressure crystallization to precipitate solids, which were dried to obtain 51.53 g of 7-dehydrocholesterol with a content of 95.4%;
[0087] The mother liquor was passed through a large-pore carboxyl weak acid resin column D131 to remove pyridine, and the obtained filtrate was concentrated under reduced pressure at 60°C to obtain 40.69g of a mixture, wherein the vitamin D3 content was 52.8wt%, the tachysterol content was 5.3wt%, the conversion rate of 7-dehydrocholesterol was 42.8%, the selectivity was 58.4%, vitamin D3 was destroyed, and 15.4% trans-vitamin D3 was generated.
[0088] Comparative Example 3 (no pyridine hydrochloride in the filter liquid)
[0089] 90 g (content 95.5%, 0.22 mol) of 7-dehydrocholesterol was dissolved in 3000 mL of ethanol, 0.35 g of pyridine and 2.01 g of butylated hydroxyanisole were added, and the solution was passed through a quartz falling film photoreactor equipped with a mercury lamp at a flow rate of 300 ml / min, with a residence time of 16 s, wherein the quartz falling film photoreactor was equipped with cooling water, and the reaction liquid temperature T1 was controlled to be 25° C., and the reaction liquid was collected;
[0090] The above reaction solution was heated at 90°C for 1 h under nitrogen protection to obtain an isomeric solution;
[0091] The isomerized liquid was passed through a quartz rising film photoreactor equipped with a mercury lamp at a flow rate of 30 ml / min, with a residence time of 600 s, wherein the quartz rising film photoreactor was equipped with a filter liquid (0.5% (2,4,6-trimethylbenzoyl) diphenylphosphine oxide and 10% ethylene glycol in deionized water), the temperature of the reaction liquid was controlled at 40°C, and the photochemical liquid was collected;
[0092] The photochemical liquid was subjected to reduced pressure crystallization to precipitate a solid, which was dried to obtain 52.26 g of 7-dehydrocholesterol with a content of 94.9%;
[0093] The mother liquor was passed through a large-pore carboxyl weak acid resin column D131 to remove pyridine, and the obtained filtrate was concentrated under reduced pressure at 60°C to obtain 44.14 g of a mixture, wherein the vitamin D3 content was 52.8 wt%, the tachysterol content was 18.6%, the conversion rate of 7-dehydrocholesterol was 42.3%, and the selectivity was 64.1%.
[0094] Comparative Example 4 (No thermal isomerization after the first photochemical reaction)
[0095] 90 g (content 95.5%, 0.22 mol) of 7-dehydrocholesterol was dissolved in 3000 mL of ethanol, 0.35 g of pyridine and 2.01 g of butylated hydroxyanisole were added, and the solution was passed through a quartz falling film photoreactor equipped with a mercury lamp at a flow rate of 300 ml / min, with a residence time of 16 s, wherein the quartz falling film photoreactor was equipped with cooling water, and the reaction liquid temperature T1 was controlled to be 25° C., and the reaction liquid was collected;
[0096] The reaction solution was passed through a quartz rising film photoreactor equipped with a mercury lamp at a flow rate of 30 ml / min, with a residence time of 600 s, wherein the quartz rising film photoreactor was equipped with a filter liquid (2.5% pyridine hydrochloride, 0.5% (2,4,6-trimethylbenzoyl) diphenylphosphine oxide and 10% ethylene glycol in deionized water), the temperature of the reaction solution was controlled at 40°C, and the photochemical solution was collected;
[0097] The photochemical liquid was subjected to reduced pressure crystallization to precipitate a solid, which was dried to obtain 55.37 g of 7-dehydrocholesterol with a content of 91.9%;
[0098] The mother liquor was passed through a large-pore carboxyl weak acid resin column D131 to remove pyridine, and the obtained filtrate was concentrated under reduced pressure at 60°C to obtain 32.66 g of a mixture, wherein the vitamin D3 content was 68.4%, the tachysterol content was 13.5%, the conversion rate of 7-dehydrocholesterol was 40.8%, and the selectivity was 63.7%.
[0099] Table 1: Comparison of conditions and yields of Examples 1 to 5 and Comparative Examples 1 to 4
[0100]
[0101]
[0102] Note: ▲ indicates that it contains (2,4,6-trimethylbenzoyl)diphenylphosphine oxide; △ indicates that it contains pyridine hydrochloride; * indicates that it contains ethylene glycol.
[0103] The embodiments described above are only used to illustrate the technical solutions of the present application, rather than to limit them. Although the present application has been described in detail with reference to the aforementioned embodiments, a person skilled in the art should understand that the technical solutions described in the aforementioned embodiments may still be modified, or some of the technical features may be replaced by equivalents. Such modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present application, and should all be included in the protection scope of the present application.
Claims
1. A Type of Vitamin D 3 The preparation method of It is characterized in that include: S1: 7-dehydrocholesterol, an organic base and an antioxidant are mixed with an organic solvent to form an organic solution, and the organic solution is continuously passed through a quartz falling film photoreactor equipped with a mercury lamp to perform a photochemical reaction; S2: collecting the photochemical reaction liquid of step S1 and performing thermal isomerization reaction; S3: The thermal isomerization reaction liquid of step S2 is continuously passed through a quartz film photoreactor equipped with a filter liquid and a mercury lamp to perform a second photochemical reaction. The reaction liquid after the photochemical reaction is concentrated under reduced pressure, crystallized, and filtered. The filtrate is concentrated after removing the organic base, and thermal isomerization is performed to obtain vitamin D. 3 product.
2. The method according to claim 1, It is characterized in that The flow rate of the organic solution in step S1 through the photoreactor is 200 ml / min to 400 ml / min, preferably 300 ml / min; optionally, the photochemical reaction temperature in step S1 is 5 to 25°C.
3. The method according to claim 1, It is characterized in that The organic base in step S1 is pyridine and / or 2-methylpyridine, and / or the molar ratio of the organic base to 7-dehydrocholesterol is 1:100 to 1:20, preferably 1:
50.
4. The method according to claim 1, It is characterized in that The antioxidant in step S1 is selected from one or a combination of butylated hydroxyanisole, 2,6-di-tert-butyl-4-methylphenol, and tert-butylhydroquinone, and / or the molar ratio of the antioxidant to 7-dehydrocholesterol is 1:(10-100), preferably 1:(10-20), and particularly preferably 1:
10.
5. The method according to claim 1, It is characterized in that The organic solvent in step S1 is selected from a mixture or monomer of alcohol, ether, and alkane with 5 to 8 carbon atoms, and / or the organic solvent in step S1 is selected from one or a combination of methanol, ethanol, and petroleum ether.
6. The method according to claim 1, It is characterized in that The thermal isomerization reaction temperature in step S2 is 60-90° C., preferably 90° C., and / or the thermal isomerization reaction time in step S2 is 1-6 h, preferably 1-3 h, particularly preferably 1 h.
7. The method according to claim 1, It is characterized in that The flow rate of the thermal isomerization reaction liquid in step S3 passing through the photoreactor is 20-50 ml / min, preferably 30 ml / min.
8. The method according to claim 1, It is characterized in that The photochemical reaction temperature of step S3 is 30-60°C, preferably 60°C, and / or the thermal isomerization and concentration of step S3 are carried out simultaneously, and / or the thermal isomerization temperature of step S3 is 60-90°C, preferably 60°C.
9. The method according to claim 1, It is characterized in that The filter liquid in step S3 includes pyridinium salt and ethylene glycol; preferably, the filter liquid in step S3 also includes a protective agent (2,4,6-trimethylbenzoyl) diphenylphosphine oxide.
10. The method according to claim 9, It is characterized in that The pyridinium salt in step S3 is a strong acid or weak acid salt of pyridine, and / or the strong acid or weak acid salt of pyridine is selected from pyridine hydrochloride, pyridine acetate, pyridine sulfate, and / or the mass fraction concentration of the pyridinium salt is 1% to 5%, preferably 2.5 to 5%, particularly preferably 2.5%, and / or the mass fraction concentration of the (2,4,6-trimethylbenzoyl)diphenylphosphine oxide is 0.1% to 1%, preferably 0.5%.
Citation Information
Patent Citations
A photochemical reaction apparatus and a method for synthesizing pre-vitamin D3
CN101085755B
Method of photochemical synthesis of vitamin Ds
US7211172B1
